Obstetricians & Gynecologists, Oncology Specialist (cancer), Surgical Specialist
7 years of experience

Accepting new patients
ACI Surgical Associates
4700 Waters Ave
Memorial Hospital - Fairfield, Savannah, GA 31404
912-350-8603
Locations and availability (3)

Education ?

Medical School Score Rankings
University of Miami (2003)
  • Currently 3 of 4 apples
Top 50%

Awards & Distinctions ?

Awards  
On-Time Doctor Award (2009)
Associations
American College of Surgeons
Member

Affiliations ?

Dr. Purinton is affiliated with 9 hospitals.

Hospital Affilations

Score

Rankings

  • Memorial Health University Medical Center
    Medical Oncology
    4700 Waters Ave, Savannah, GA 31404
    • Currently 4 of 4 crosses
    Top 25%
  • UT Southwestern University Hospital - Zale Lipshy
    5151 Harry Hines Blvd, Dallas, TX 75235
    • Currently 4 of 4 crosses
    Top 25%
  • Candler Hospital
    Medical Oncology
    5353 Reynolds St, Savannah, GA 31405
    • Currently 2 of 4 crosses
  • St Joseph's Hospital - Savannah
    Medical Oncology
    11705 Mercy Blvd, Savannah, GA 31419
    • Currently 1 of 4 crosses
  • Parkland Health & Hospital System
    5201 Harry Hines Blvd, Dallas, TX 75235
    • Currently 1 of 4 crosses
  • Memorial Medical Center
  • Parkland Health And Hospital System
  • Zale Lipshy
  • Ut Southwestern University Hospitals
  • Publications & Research

    Dr. Purinton has contributed to 6 publications.
    Title Tumor Antigen Acrosin Binding Protein Normalizes Mitotic Spindle Function to Promote Cancer Cell Proliferation.
    Date November 2010
    Journal Cancer Research
    Excerpt

    Cancer cells manage to divide in the context of gross chromosomal abnormalities. These abnormalities can promote bypass of normal restraints on cell proliferation but at a cost of mitotic vulnerabilities that can be attacked by chemotherapy. Determining how cancer cells balance these issues may permit chemotherapeutic sensitivity to be leveraged more efficiently. From a pan-genomic small interfering RNA screen for modifiers of chemoresponsiveness, we identified the tumor antigen acrosin binding protein (ACRBP)/OY-TES-1 as a specifier of paclitaxel resistance. ACRBP expression is normally restricted to the testes but is detected in a wide variety of cancers, including most ovarian cancers. We found that ACRBP is both necessary and sufficient for paclitaxel resistance in ovarian cancer cell lines and ovarian tumor explants. Moreover, high ACRBP expression correlated with reduced survival time and faster relapse among ovarian cancer patients. We identified the mitotic spindle protein NuMA as an ACRBP-interacting protein that could account for the effects of ACRBP on paclitaxel sensitivity. In cancer cells, ACRBP restricted a NuMA-dependent abrogation of a mitotic spindle assembly that is otherwise pathologic. As a consequence, ACRBP depletion resulted in mitotic errors and reduced proliferative fitness that could be rescued by NuMA codepletion. We propose that the codependent relationship of ACRBP and NuMA in cancer cells reflects their passage through a selection bottleneck during tumor evolution, one which requires the acquisition of traits that normalize mitotic perturbations that originally drove the plasticity of a preneoplastic genome. The molecular definition of such traits as defined by the ACRBP-NuMA complex may represent conceptually ideal intervention targets based on the wide therapeutic windows they may offer.

    Title Cost-effectiveness of Routine Vaginal Cytology for Endometrial Cancer Surveillance.
    Date December 2006
    Journal Gynecologic Oncology
    Excerpt

    OBJECTIVE: To examine the cost-effectiveness of routine vaginal cytology in detecting asymptomatic isolated vaginal recurrence during post-treatment endometrial cancer surveillance. METHODS: All patients treated for endometrial cancer between 7/1/97 and 6/30/2005 were retrospectively identified from the tumor registry database. Clinico-pathologic characteristics and surveillance testing data were abstracted from medical records. The total number of Pap tests performed during surveillance or until the time of recurrence was calculated and charges associated with detecting asymptomatic isolated vaginal recurrence assigned based on 2005 Pap test costs adjusted retroactively using the consumer price index. RESULTS: Three hundred seventy-seven patients met inclusion criteria: FIGO Stage I=63.7%, Stage II=10.1%, Stage III=18.8%, Stage IV=7.4%. The median follow-up time was 30.4 months. A total of 2,134 Pap tests were collected during the study interval (median 5, mean 5.76 samples/patient). Endometrial cancer recurred in 61 patients (16.2%); 11 patients (2.9%) had an isolated vaginal recurrence. Seven isolated vaginal recurrences were detected by physical examination alone, and 2 were detected by interval computed tomography. An asymptomatic isolated vaginal recurrence was detected by routine vaginal cytology in 2 of 377 patients (0.5%). Detection of each asymptomatic vaginal recurrence required 1067 Pap tests, generating 44,049 US dollar in cumulative charges. CONCLUSIONS: As a surveillance test for endometrial cancer recurrence, routine vaginal cytology is costly, inefficient, and benefits less than 1% of patients. Elimination or reduction in the use of vaginal cytology for this purpose offers an opportunity for significant cost savings in gynecologic oncology health care expenditure.

    Title Oestrogen Augments the Fetal Ovine Hypothalamus- Pituitary-adrenal Axis in Response to Hypotension.
    Date April 2003
    Journal The Journal of Physiology
    Excerpt

    In the fetal sheep, parturition is triggered by an increase in the activity of the fetal hypothalamus- pituitary-adrenal (HPA) axis which, in turn, augments the biosynthesis of oestrogen by the placenta. Parturition can be prevented or delayed by destruction of the paraventricular nucleus (PVN), pituitary or adrenal, or stimulated by infusions of adrenocorticotropin (ACTH) or glucocorticoids. We have previously reported that physiological increases in fetal plasma concentrations of oestradiol have a neuroendocrine effect to increase both basal and hypotension-stimulated ACTH secretion. The present study was performed to test the effect of oestradiol on the central baroreceptor and chemoreceptor reflex pathways. We used immunohistological techniques to identify various neuroanatomical regions which are activated by hypotension and, subsequently, those areas modified by oestrogen's action and baroreceptor and chemoreceptor denervation. We assessed cellular activation in these brain regions by immunostaining for Fos, the protein product of c-fos, an immediate early response gene. We found that oestradiol increased Fos abundance in nucleus tractus solitarius (NTS), rostral ventrolateral medulla (RVLM), and PVN, and augmented the increase in Fos in these regions in response to a 10 min period of brachiocephalic arterial occlusion (BCO). Carotid sinus denervation blocked the Fos response to BCO, but not to oestrogen alone, in these regions. In contrast, the hippocampus responded to BCO with increase Fos in intact fetuses, but did not respond to oestrogen treatment. None of the treatments altered Fos expression in cerebral cortex or in cerebellum. We conclude that oestradiol augments the activity of the central baroreceptor and chemoreceptor reflex pathways, and that it may influence fetal ACTH secretion via this site of action.

    Title Ovine Fetal Estrogen Sulfotransferase in Brain Regions Important for Hypothalamus-pituitary-adrenal Axis Control.
    Date June 2000
    Journal Neuroendocrinology
    Excerpt

    Ovine parturition is initiated by increases in fetal hypothalamus-pituitary-adrenal (HPA) axis activity which, in turn, increase placental estrogen biosynthesis and ultimately increase uterine contractility. In addition to their action in the uterus, estrogens in fetal plasma augment fetal corticotropin (ACTH) secretion. In late gestation, estrone sulfate is more abundant in fetal plasma than unconjugated estrone and it is possible that there is interconversion of sulfoconjugated and unconjugated steroids within the fetal brain. We studied hypothalamus and brainstem tissue from fetal, neonatal, and adult sheep to test the hypothesis that the ovine brain contains estrogen sulfotransferase. Although no significant ontogenic pattern was revealed, the presence of estrogen sulfotransferase within the hypothalamus and brainstem was detectable. Immunohistochemistry revealed the presence of estrogen sulfotransferase in the paraventricular nucleus of the hypothalamus, the nucleus of the tractus solatarius, and the rostral ventral lateral medulla. We conclude that ovine fetal hypothalamus and brainstem contain estrogen sulfotransferase in brain regions important for HPA axis control.

    Title Ontogeny of Estrogen Sulfatase Activity in Ovine Fetal Hypothalamus, Hippocampus, and Brain Stem.
    Date July 1999
    Journal The American Journal of Physiology
    Excerpt

    Ovine parturition is initiated by increases in fetal hypothalamus-pituitary-adrenal (HPA) axis activity, which in turn increase placental estrogen biosynthesis and ultimately increase uterine contractility. In addition to the action in the uterus, estrogens augment fetal ACTH secretion. In late gestation, estrone sulfate is more abundant in fetal plasma than is unconjugated estrone. We studied hypothalamus, hippocampus, and brain stem tissue from fetal, neonatal, and adult sheep to test the hypothesis that the ovine brain contains estrogen sulfatase activity. We found that the activity in the hippocampus was significantly increased in late-gestation fetuses compared with both younger and older animals. No significant change in either hypothalamus or brain stem was revealed; however, the activity in all brain areas was high. Immunohistochemistry revealed the presence of estrogen sulfatase in the paraventricular nucleus of the hypothalamus, the nucleus of the solitary tract, and the rostral ventrolateral medulla. We conclude that ovine fetal hypothalamus, hippocampus, and brain stem contain estrogen sulfatase activity and that the activity in the hippocampus is developmentally regulated.

    Title Thromboxane A2 Acts at a Site Perfused by the Carotid Vasculature to Mediate Cardiovascular and Adrenocortical Responses.
    Date August 1997
    Journal Canadian Journal of Physiology and Pharmacology
    Excerpt

    Increases in thromboxane A2 (TxA2) synthesis are associated with hemodynamic responses and activation of the hypothalamus-pituitary-adrenal axis. This study tested the hypothesis that TxA2 acts on a site perfused by the carotid vasculature to mediate these responses. The TxA2 mimetic U46619 was infused for 30 min into the carotid artery or the vena cava of chronically instrumented adult sheep at doses of 0, 0.25, 0.5, and 1.0 microgram.kg-1.min-1. Mean arterial pressure increased in response to carotid or vena cava U46619 infusions of 0.5 and 1.0 microgram.kg-1.min-1. Heart rate was elevated in response to carotid (0.5 and 1.0 microgram.kg-1.min-1) or vena cava (1.0 microgram.kg-1.min-1) infusions of U46619. Paco2 declined and pH2 increased significantly in response to carotid infusions of 0.5 and 1.0 microgram.kg-1.min-1 but did not change in response to vena cava infusions. Adrenocorticotropic hormone (ACTH) increased in response to carotid infusions of 0.5 microgram.kg-1.min-1, while cortisol increased in response to infusions of 0.25, 0.5, and 1.0 microgram.kg-1.min-1. ACTH and cortisol did not change in response to vena cava infusions. Pao2, hematocrit, and arginine vasopressin did not change significantly. Pulmonary artery pressure and total peripheral resistance increased while cardiac output decreased in response to carotid or vena cava U46619 infusions of 1 microgram.kg-1.min-1; carotid and vena cava responses were not different from one another. We conclude that increases in blood pressure are mediated by peripheral PGH2/TxA2 receptor activation and that pituitary adrenal, blood gas, and heart rate responses are mediated by PGH2/TxA2 receptor activation at a site perfused by the carotid vasculature.

    Similar doctors nearby

    Dr. John Fontana

    Obstetrics & Gynecology
    43 years experience
    Beaufort, SC

    Dr. Glenn Werner

    Obstetrics & Gynecology
    28 years experience
    Beaufort, SC

    Dr. Glenn Love

    Obstetrics & Gynecology
    45 years experience
    Hilton Head Island, SC

    Dr. Harry Collins

    Emergency Medicine
    29 years experience
    Pooler, GA

    Dr. Karen Tapp

    Obstetrics & Gynecology
    10 years experience
    Savannah, GA

    Dr. Karen Fehr-D'Alessandro

    Obstetrics & Gynecology
    20 years experience
    Savannah, GA
    Search All Similar Doctors